DVA – DaVita Inc.
DVA — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
9.27
Margin Of Safety %
5
Put/Call OI Ratio
0.92
EPS Next Q Diff
0.26
EPS Last/This Y
4.02
EPS This/Next Y
2.25
Price
149.77
Target Price
151
Analyst Recom
2.82
Performance Q
31.38
Upside
123.3%
Beta
0.9
Ticker: DVA
18 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | DVA | 152.5 | 1.43 | 0.30 | 36334 |
| 2026-03-10 | DVA | 151.57 | 1.46 | 0.14 | 36047 |
| 2026-03-11 | DVA | 154.83 | 1.48 | 0.29 | 35903 |
| 2026-03-12 | DVA | 153.15 | 1.47 | 0.59 | 35960 |
| 2026-03-17 | DVA | 150.01 | 1.43 | 1.08 | 37017 |
| 2026-03-18 | DVA | 148.83 | 1.42 | 1.74 | 36993 |
| 2026-03-19 | DVA | 149.85 | 1.42 | 1.11 | 37034 |
| 2026-03-20 | DVA | 149.32 | 1.41 | 0.00 | 36737 |
| 2026-03-23 | DVA | 152.33 | 0.96 | 0.05 | 22746 |
| 2026-03-24 | DVA | 153.25 | 0.95 | 0.55 | 22837 |
| 2026-03-25 | DVA | 155.15 | 0.95 | 0.83 | 22863 |
| 2026-03-26 | DVA | 156.88 | 0.95 | 2.04 | 22909 |
| 2026-03-27 | DVA | 154.32 | 0.95 | 0.15 | 22990 |
| 2026-03-30 | DVA | 152.37 | 0.92 | 0.58 | 23414 |
| 2026-03-31 | DVA | 153.72 | 0.90 | 0.77 | 23815 |
| 2026-04-01 | DVA | 150.37 | 0.92 | 1.38 | 23536 |
| 2026-04-02 | DVA | 146.17 | 0.92 | 1.35 | 23550 |
| 2026-04-07 | DVA | 149.77 | 0.92 | 2.17 | 23630 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
18 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | DVA | 152.55 | 15.9 | 223.9 | 14.05 |
| 2026-03-10 | DVA | 151.60 | 15.9 | 206.3 | 14.05 |
| 2026-03-11 | DVA | 154.91 | 15.9 | 233.9 | 14.05 |
| 2026-03-12 | DVA | 153.13 | 15.9 | 201.7 | 14.05 |
| 2026-03-13 | DVA | 150.72 | 15.9 | 197.5 | 14.05 |
| 2026-03-17 | DVA | 150.01 | 15.9 | 224.0 | 14.08 |
| 2026-03-18 | DVA | 148.90 | 15.9 | 205.5 | 14.08 |
| 2026-03-19 | DVA | 149.79 | 15.9 | 173.3 | 14.08 |
| 2026-03-20 | DVA | 149.31 | 15.9 | 164.4 | 14.08 |
| 2026-03-23 | DVA | 152.27 | 15.9 | 185.9 | 14.08 |
| 2026-03-24 | DVA | 153.28 | 15.9 | 173.9 | 14.08 |
| 2026-03-25 | DVA | 155.15 | 15.9 | 178.8 | 14.08 |
| 2026-03-26 | DVA | 156.79 | 15.9 | 177.5 | 14.08 |
| 2026-03-27 | DVA | 154.40 | 15.9 | 152.6 | 14.08 |
| 2026-03-30 | DVA | 152.35 | 15.9 | 154.2 | 14.08 |
| 2026-03-31 | DVA | 153.76 | 15.9 | 175.8 | 14.08 |
| 2026-04-01 | DVA | 150.40 | 15.9 | 146.7 | 14.08 |
| 2026-04-02 | DVA | 145.59 | 15.9 | 137.3 | 14.08 |
| 2026-04-06 | DVA | 150.16 | 15.9 | 196.4 | 14.08 |
| 2026-04-07 | DVA | 149.77 | 15.9 | 164.9 | 14.08 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | DVA | -36.26 | -0.69 | 10.38 |
| 2026-03-10 | DVA | -36.26 | -0.69 | 10.38 |
| 2026-03-11 | DVA | -36.26 | -0.69 | 9.57 |
| 2026-03-12 | DVA | -36.26 | -0.69 | 9.57 |
| 2026-03-13 | DVA | -36.26 | -0.69 | 9.57 |
| 2026-03-17 | DVA | -36.26 | -0.59 | 9.57 |
| 2026-03-18 | DVA | -36.26 | -0.59 | 9.57 |
| 2026-03-19 | DVA | -36.26 | -0.59 | 9.57 |
| 2026-03-20 | DVA | -36.26 | -0.59 | 9.57 |
| 2026-03-23 | DVA | -36.26 | -0.61 | 9.57 |
| 2026-03-24 | DVA | -36.26 | -0.61 | 9.57 |
| 2026-03-25 | DVA | -36.26 | -0.61 | 9.27 |
| 2026-03-26 | DVA | -36.26 | -0.61 | 9.27 |
| 2026-03-27 | DVA | -36.26 | -0.61 | 9.27 |
| 2026-03-30 | DVA | -36.26 | -0.61 | 9.27 |
| 2026-03-31 | DVA | -36.26 | -0.61 | 9.27 |
| 2026-04-01 | DVA | -36.26 | -0.61 | 9.27 |
| 2026-04-02 | DVA | -36.26 | -0.61 | 9.27 |
| 2026-04-06 | DVA | -36.26 | -0.63 | 9.27 |
| 2026-04-07 | DVA | -36.26 | -0.63 | 9.27 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
3.4
Avg. EPS Est. Current Quarter
2.32
Avg. EPS Est. Next Quarter
3.66
Insider Transactions
-36.26
Institutional Transactions
-0.63
Beta
0.9
Average Sales Estimate Current Quarter
3356
Average Sales Estimate Next Quarter
3472
Fair Value
156.73
Quality Score
63
Growth Score
82
Sentiment Score
41
Actual DrawDown %
16.6
Max Drawdown 5-Year %
-51.1
Target Price
151
P/E
15.67
Forward P/E
9.2
PEG
0.48
P/S
0.73
P/B
P/Free Cash Flow
7.62
EPS
9.55
Average EPS Est. Cur. Y
14.08
EPS Next Y. (Est.)
16.33
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
5.29
Relative Volume
0.59
Return on Equity vs Sector %
-142.2
Return on Equity vs Industry %
-248.6
EPS 1 7Days Diff
EPS 1 30Days Diff
1.33
EBIT Estimation
164.9
◆
DVA
Healthcare
$149.70
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
2/20
Pullback
17/25
Volume
11/15
Valuation
12/20
TP/AR
0/10
Options
2/10
RSI
50.3
Range 1M
40.3%
Sup Dist
2.1%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
5/25
Growth
14/30
Estimates
5/20
Inst/Vol
4/15
Options
3/10
EPS Yr
31.1%
EPS NY
15.1%
52W%
83.5%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+142.5% upside
Quality
13/30
Valuation
23/30
Growth
14/25
Stability
6/10
LT Trend
0/5
Upside
+142.5%
Quality
63
MoS
5%
Click a card to see score breakdown
Full Analysis →
Sector: Healthcare
Industry: Medical Care Facilities
Employees: 78000
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
DVA
Latest News
—
Caricamento notizie per DVA…
stock quote shares DVA – DaVita Inc. Stock Price stock today
news today DVA – DaVita Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DVA – DaVita Inc. yahoo finance google finance
stock history DVA – DaVita Inc. invest stock market
stock prices DVA premarket after hours
ticker DVA fair value insiders trading